Article Details
Retrieved on: 2021-08-16 15:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Strong results boost approval chances for Pfizer's hair loss drug. Pfizer's PF-06651600 (ritlecitinib) saw its LoA jump by 10 points to 23% in alopecia ...
Article found on: www.clinicaltrialsarena.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here